Aducanumab: 4 in 10 high dose trial participants experienced brain swelling or bleeding
Over 40% of trial participants who had a high dose (10 mg/kg) of the Alzheimer’s disease drug aducanumab experienced brain swelling or bleeding, research has shown.1Aducanumab, which costs $56 000…
